We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Case report: A report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy.
- Authors
Xi Zhang; Hao Tang; Jun Fan; Rui Wang; Yunwei Han; Song Su; Yu Gan; Fangyi Peng; Mingyue Rao; Jianwen Zhang; Bo Li; Xiaoli Yang
- Abstract
Cholangiocarcinoma (CCA) is a rare disease with poor prognosis, and surgery remains the only curative treatment option. However, surgery is inappropriate for the majority of patients with CCA. Conversion therapy may provide opportunities for the surgical treatment of these patients. Herein, we describe a patient with intrahepatic CCA who was first treated with albuminbound paclitaxel, cisplatin, and gemcitabine in combination with camrelizumab. The patient then successfully underwent surgery and achieved pathological complete remission. This report can serve as a reference for clinicians regarding conversion therapy for intrahepatic CCA.
- Subjects
CONVERSION therapy; CHOLANGIOCARCINOMA; PROGNOSIS; PACLITAXEL; CISPLATIN
- Publication
Frontiers in Immunology, 2022, Vol 13, p1
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2022.1051130